Sandbox/00007: Difference between revisions

Jump to navigation Jump to search
Line 201: Line 201:


* ''Initial Management''
* ''Initial Management''
::* [[Resuscitation]] should be initiated while investigation is ongoing. Correct the cause of [[shock]] immediately once it is identified.
::* The VIP (Ventilate-Infuse-Pump) approach is useful for ensuring an orderly sequence of therapeutic-diagnostic maneuvers.<ref name="Weil-1969">{{Cite journal  | last1 = Weil | first1 = MH. | last2 = Shubin | first2 = H. | title = The VIP approach to the bedside management of shock. | journal = JAMA | volume = 207 | issue = 2 | pages = 337-40 | month = Jan | year = 1969 | doi =  | PMID = 5818156 }}</ref>


:* ''Ventilate''
:* Ventilatory support is crucial for maintenance of adequate oxygenation and usually requires intubation with mechanical ventilation.
::* [[Endotracheal intubation]] should be performed in patients with severe [[dyspnea]], [[hypoxemia]], or persistent or worsening [[acidemia]] (pH <7.30).
:* Optimization of [[hemodynamic|hemodynamic status]] may be initially achieved by judicious administration of [[diuretic]]s, [[vasopressor]]s, [[vasodilator]]s, [[inotrope]]s, and/or [[intravenous fluid]]s.
 
:* [[intravenous therapy|IV]] bolus [[normal saline]] should be waived in the presence of [[pulmonary edema]].
:* ''Infuse''
:* End point of fluid therapy may be defined as a [[central venous pressure|central venous pressure (CVP)]] of a few [[mmHg|millimeters of mercury (mmHg)]] above the baseline to prevent fluid overload.<ref name="Dellinger-2013">{{Cite journal  | last1 = Dellinger | first1 = RP. | last2 = Levy | first2 = MM. | last3 = Rhodes | first3 = A. | last4 = Annane | first4 = D. | last5 = Gerlach | first5 = H. | last6 = Opal | first6 = SM. | last7 = Sevransky | first7 = JE. | last8 = Sprung | first8 = CL. | last9 = Douglas | first9 = IS. | title = Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. | journal = Crit Care Med | volume = 41 | issue = 2 | pages = 580-637 | month = Feb | year = 2013 | doi = 10.1097/CCM.0b013e31827e83af | PMID = 23353941 }}</ref>
::* A [[intravenous therapy#Central IV lines|central venous catheter]] should be placed for the infusion of fluids and [[vasopressor|vasoactive agent]]s and to guide fluid therapy.
::* A [[pulmonary artery catheter]] should be inserted for monitoring of [[blood pressure]] and [[sampling|blood sampling]] unless shock is rapidly reversed. '''''([[Right heart catheterization#Indications|Indications]])'''''
::* An infusion of 300–500 ml of [[Intravenous fluid#Crystalloid Fluids|crystalloid fluid]] is usually administered during a period of 20–30 minutes.
::* End point of fluid therapy can be defined as a [[central venous pressure|central venous pressure (CVP)]] of a few [[mmHg|millimeters of mercury (mmHg)]] above the baseline to prevent fluid overload.<ref name="Dellinger-2013">{{Cite journal  | last1 = Dellinger | first1 = RP. | last2 = Levy | first2 = MM. | last3 = Rhodes | first3 = A. | last4 = Annane | first4 = D. | last5 = Gerlach | first5 = H. | last6 = Opal | first6 = SM. | last7 = Sevransky | first7 = JE. | last8 = Sprung | first8 = CL. | last9 = Douglas | first9 = IS. | title = Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. | journal = Crit Care Med | volume = 41 | issue = 2 | pages = 580-637 | month = Feb | year = 2013 | doi = 10.1097/CCM.0b013e31827e83af | PMID = 23353941 }}</ref>
 
:* ''Pump''
::* [[Vasopressor]]s are indicated in [[hypotension]] that is severe or refractory to fluid challenge.
::* [[Norepinephrine]] (0.1–2.0 μg/kg/min IV) is the first choice of [[vasopressor]], while [[epinephrine]] (0.1–0.5 μg/kg/min IV) is reserved for severe [[hypotension]] as the second-line agent.
::* [[Isoproterenol]] (0.5–5.0 μg/min IV) should be limited to the treatment of [[hypotensive]] patients with severe [[bradycardia]].
::* Adjunctive [[vasopressin]] (0.01–0.04 U/min IV) to [[norepinephrine]] should be considered only in hyperdynamic phase of [[distributive shock]].


==Don'ts==
==Don'ts==

Revision as of 17:30, 18 April 2014

Cardiogenic Shock
Resident Survival Guide
Overview
Causes
FIRE
Diagnosis
Treatment
Do's
Don'ts

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, MBChB. [2]

Overview

The clinical definition of cardiogenic shock includes decreased cardiac output with evidence of tissue hypoxia in the presence of adequate intravascular volume.[1]

Diagnositic Criteria

Criteria for bedside diagnosis[1][2][3]

Criteria based on hemodynamic parameters[1][3][4][5][6]

Causes

Life Threatening Causes

Cardiogenic shock is a life-threatening condition and must be treated as such irrespective of the underlying cause.

Common Causes

  • Arrhythmic
  • Mechanical
  • Myopathic
  • Pharmacologic

Click here for the complete list of causes.

FIRE: Focused Initial Rapid Evaluation

A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients in need of immediate intervention.

Boxes in the salmon color signify that an urgent management is needed.

Abbreviations: CBC, complete blood count; CI, cardiac index; CK-MB, creatine kinase MB isoform; CVP, central venous pressure; DC, differential count; ICU, intensive care unit; INR, international normalized ratio; LFT, liver function test; MAP, mean arterial pressure; MVO2, mixed venous oxygen saturation; PCWP, pulmonary capillary wedge pressure; PT, prothrombin time; PTT, partial prothrombin time; SaO2, arterial oxygen saturation; SBP, systolic blood pressure; SCVO2, central venous oxygen saturation; SMA-7, sequential multiple analysis-7.

 
 
 
 
Does the patient have cardinal findings that increase the pretest probability of cardiogenic shock?

❑  Evidence of hypoperfusion

❑  Altered mental status
❑  Cool extremities
❑  Cyanosis
❑  Oliguria
❑  Sustained hypotension
❑  SBP <90 mm Hg for ≥30 min or
❑  MAP ↓ >30 mm Hg below baseline for ≥30 min
❑  Presence of myocardial dysfunction after exclusion or correction of non-myocardial factors contributing to tissue hypoperfusion
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
YES
 
 
 
 
 
NO
 
 
 
 
 
 
 
 
 
 
 
 
 
Cardiogenic
shock
suspected
 
 
 
 
 
Proceed to
shock resident survival guide
to identify and correct the cause
 
 
 
 
 
 
 
 
 
 
 
 
Immediate management

❑  Intubation with mechanical ventilation

❑  ± IV bolus normal saline 100–200 mL

❑  ± Norepinephrine 0.1–2.0 μg/kg/min

❑  ± Control pain and/or anxiety

❑  Morphine sulphate
❑  Fentanyl
❑  Cardiology consultation
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Immediate goals

❑  SaO2 >90%–92%

❑  CVP 8–12 mm Hg

❑  MAP >60 mm Hg

❑  PCWP 14–18 mm Hg

❑  CI >2.2 L/min/m2

❑  MVO2 >60%

❑  SCVO2 >70%

❑  Hemoglobin >7–9 g/dL

❑  Lactate <2.2 mM/L

❑  Urine output >0.5 mL/kg/h

❑  ± Correct arrhythmia

❑  ± Correct electrolyte disturbance
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

Complete Diagnostic Approach

Treatment

Do's

  • Initial Management

Don'ts

References

  1. 1.0 1.1 1.2 Califf, RM.; Bengtson, JR. (1994). "Cardiogenic shock". N Engl J Med. 330 (24): 1724–30. doi:10.1056/NEJM199406163302406. PMID 8190135. Unknown parameter |month= ignored (help)
  2. Hollenberg, SM.; Kavinsky, CJ.; Parrillo, JE. (1999). "Cardiogenic shock". Ann Intern Med. 131 (1): 47–59. PMID 10391815. Unknown parameter |month= ignored (help)
  3. 3.0 3.1 Goldberg, RJ.; Gore, JM.; Alpert, JS.; Osganian, V.; de Groot, J.; Bade, J.; Chen, Z.; Frid, D.; Dalen, JE. (1991). "Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988". N Engl J Med. 325 (16): 1117–22. doi:10.1056/NEJM199110173251601. PMID 1891019. Unknown parameter |month= ignored (help)
  4. Forrester, JS.; Diamond, G.; Chatterjee, K.; Swan, HJ. (1976). "Medical therapy of acute myocardial infarction by application of hemodynamic subsets (first of two parts)". N Engl J Med. 295 (24): 1356–62. doi:10.1056/NEJM197612092952406. PMID 790191. Unknown parameter |month= ignored (help)
  5. Forrester, JS.; Diamond, G.; Chatterjee, K.; Swan, HJ. (1976). "Medical therapy of acute myocardial infarction by application of hemodynamic subsets (second of two parts)". N Engl J Med. 295 (25): 1404–13. doi:10.1056/NEJM197612162952505. PMID 790194. Unknown parameter |month= ignored (help)
  6. Reynolds, HR.; Hochman, JS. (2008). "Cardiogenic shock: current concepts and improving outcomes". Circulation. 117 (5): 686–97. doi:10.1161/CIRCULATIONAHA.106.613596. PMID 18250279. Unknown parameter |month= ignored (help)
  7. Dellinger, RP.; Levy, MM.; Rhodes, A.; Annane, D.; Gerlach, H.; Opal, SM.; Sevransky, JE.; Sprung, CL.; Douglas, IS. (2013). "Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012". Crit Care Med. 41 (2): 580–637. doi:10.1097/CCM.0b013e31827e83af. PMID 23353941. Unknown parameter |month= ignored (help)